<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02076087</url>
  </required_header>
  <id_info>
    <org_study_id>2013-02113</org_study_id>
    <nct_id>NCT02076087</nct_id>
  </id_info>
  <brief_title>Immune Characterization of Subcutaneous Adipose Tissue</brief_title>
  <acronym>ATI</acronym>
  <official_title>Immune Characterization of Subcutaneous Adipose Tissue</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Washington University School of Medicine</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Washington University School of Medicine</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The overall goal of this proposal is to characterize the immune cell profile of subcutaneous
      abdominal adipose tissue in lean, overweight, obese and lipedema adults, and to evaluate
      potential associations between different adipose tissue immune cell types and metabolic
      profile.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">February 2014</start_date>
  <completion_date type="Actual">September 2017</completion_date>
  <primary_completion_date type="Actual">September 2017</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Other</observational_model>
    <time_perspective>Cross-Sectional</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Determine the types of immune cells and the relative prevalence of each type and sub-type, in subcutaneous adipose tissue of normal weight, overweight, obese and lipedema adults.</measure>
    <time_frame>intraoperative</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Determine the relationships among specific types and subtypes of immune cells, adiposity and cardiometabolic risk.</measure>
    <time_frame>Baseline</time_frame>
  </secondary_outcome>
  <number_of_groups>3</number_of_groups>
  <enrollment type="Actual">19</enrollment>
  <condition>Determine Immune Cell Types in Subcutaneous Adipose Tissue</condition>
  <arm_group>
    <arm_group_label>Normal Weight (BMI: 18.5-24.9 kg/m²)</arm_group_label>
    <description>Liposuction/lipectomy</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Overweight (BMI: 25.0-29.9 kg/m²)</arm_group_label>
    <description>Liposuction/lipectomy</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Obese (BMI: &gt;30.0kg/m²)</arm_group_label>
    <description>Liposuction/lipectomy</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Liposuction/lipectomy</intervention_name>
    <description>Subcutaneous adipose tissue will be obtained from liposuction/lipectomy to determine the types of immune cells</description>
    <arm_group_label>Normal Weight (BMI: 18.5-24.9 kg/m²)</arm_group_label>
    <arm_group_label>Overweight (BMI: 25.0-29.9 kg/m²)</arm_group_label>
    <arm_group_label>Obese (BMI: &gt;30.0kg/m²)</arm_group_label>
  </intervention>
  <biospec_retention>Samples With DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      Serum and plasma samples will be obtained Abdominal and thigh subcutaneous adipose tissue
      obtained during surgery
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        50 women already scheduled to undergo liposcution/lipectomy procedure for breast
        reconstruction associated with prophylactic mastectomy or mastectomy for in situ ductal
        breast corcinoma, cosmetic surgery, or abdominal lipectomy for severe obesity at either
        Barnes-Jewish Hospital or Barnes-Jewish West County Hospital. Subjects of all races and
        ethnicity, with a body mass index (BMI) greater than or equal to 18.5 kg/m² and between the
        ages of 18 and 65 years of age will be included in the study.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Women of all races and ethnicity

          -  Age between 18 and 65 years

          -  Body Mass Index (BMI) ≥ 18.5 kg/m²

          -  Weight stable (+/- 3% during the last 2 months before enrollment)

          -  Women already scheduled for above mentioned procedures

        Exclusion Criteria:

          -  Diabetes Mellitus

          -  Recent (&lt;5 years) history of cancer (except in situ ductal breast carcinoma)

          -  Chemotherapy and/or radiation therapy within 4 months before enrollment

          -  Immune system diseases (i.e., autoimmune disorders, acquired immunodeficiency
             syndrome)

          -  Pregnant or breastfeeding

          -  Take any medication that might affect immune function

          -  Severe organ dysfunction

          -  BMI &lt;18.5 kg/m² or size of each breast is &gt;600 grams, if scheduled for bilateral
             breast reconstruction
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Samuel Klein, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Washington University School of Medicine</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Washington University School of Medicine</name>
      <address>
        <city>Saint Louis</city>
        <state>Missouri</state>
        <zip>63110</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>September 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>February 27, 2014</study_first_submitted>
  <study_first_submitted_qc>February 28, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 3, 2014</study_first_posted>
  <last_update_submitted>September 6, 2017</last_update_submitted>
  <last_update_submitted_qc>September 6, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">September 7, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Subcutaneous adipose tissue</keyword>
  <keyword>Lipectomy</keyword>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

